This may involve genes encoding for perforin (PRF1), osteopontin (OPN), and Signaling Lymphocyte Activation Molecule-Associated Protein (SH2D1A), whose variations have been suggested to be risk factors for ALPS or DALD development. This evidence concerns the gene SH2D1A and Dianzani autoimmune lymphoproliferative disease.